Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
AIDS activists demand access to important cryptococcal meningitis drug
Call to action NewsAt the 10th International HIV Conference on Science (IAS 2019) taking place in Mexico City, AIDS activists protested Gilead’s inaction...
Read more about AIDS activists demand access to important cryptococcal meningitis drug
-
The right to health is compulsory: Time for action on dolutegravir – now!
Call to action News ResearchWhy Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...
Read more about The right to health is compulsory: Time for action on dolutegravir – now!
-
Still an avoidable tragedy: Brazil’s view on the EU-Mercosur free-trade agreement
News OpinionThe signing of the Free Trade Agreement (FTA) between Mercosur and the European Union on 28 June 2019, means that...
Read more about Still an avoidable tragedy: Brazil’s view on the EU-Mercosur free-trade agreement
-
Old wine in new bottles: Keep TRIPS-plus provisions out of the RCEP FTA!
OpinionIntellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement...
Read more about Old wine in new bottles: Keep TRIPS-plus provisions out of the RCEP FTA!
-
Ukraine hosts regional congress on intellectual property and access to medicines
NewsOver 100 people from more than 10 countries met in Kiev for the ‘Congress on Intellectual Property (IP) and Access...
Read more about Ukraine hosts regional congress on intellectual property and access to medicines
-
Drug users under the microscope: Temo’s experience in Georgia
Interview“I was in prison when I was diagnosed with Hepatitis B,” says Temo, 33. “I was just left with the...
Read more about Drug users under the microscope: Temo’s experience in Georgia
-
Ukraine: First civil society organization to oppose Merck’s patent application ( MK-8591) on the grounds of “obviousness”
NewsOn 28 May 2019, 100 Percent Life (the Network) submitted an opposition to the Ukrainian Patent and Trademark Office against...
-
Politics of Death: The End of Brazil’s Department of AIDS
News OpinionAdapted from a post published by ABIA, Global AIDS Policy Watch: A joint story from Brazilian NGOs that have denounced...
Read more about Politics of Death: The End of Brazil’s Department of AIDS
-
Pipeline patents – Brazilian Supreme Court decides on the present and the future
NewsOn Wednesday 22 May, the largest trial in the history of the Brazilian Federal Supreme Court (STF) involving the pharmaceutical...
Read more about Pipeline patents – Brazilian Supreme Court decides on the present and the future
-
Truvada for PrEP. Gilead grilled at US congressional hearing
NewsThe USA is being charged $70 per pill for a drug, yet tax payers largely funded the research. Thanks to...
Read more about Truvada for PrEP. Gilead grilled at US congressional hearing